Delivery Order SPE2DB20D3101-SPE2DB25FRLF1
Award Date
5/27/25
Potential Completion Date
5/28/25
Potential Value
$2.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 120 tablets of the medication Alfuzosin HCl ER 10 mg, a treatment for enlarged prostate. The contract is a Firm Fixed Price award with a ceiling value of $1,888.77 and a performance period extending through June 13, 2025. This contract is not set aside and was competed openly....
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,252.55 firm fixed-price contract is for the delivery of 1,000 units of Alfuzosin HCl ER 10 mg tablets, a medication used to treat enlarged prostate. The contract has an ultimate completion date of March 14, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The contract, which is not set-aside, has a firm-fixed price of $1,225.68 and a completion date of May 22, 2025. It covers the delivery of 120 tablets of the medication Alfuzosin Hydrochloride Extended Release 10 mg. Amerisourcebergen Drug Corp holds a significant Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Alfuzosin HCl ER 10 mg tablets, a medication used to treat benign prostatic hyperplasia. The contract has a firm fixed price of $6,005.91 and a completion date of June 10, 2025. The contract is not set aside and is open to full and open competition. AmerisourceBergen Drug Corp...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,584.96 firm fixed-price delivery order is for the supply of 90-tablet bottles of Alfuzosin HCL ER 10 mg, a medication used to treat enlarged prostate. The contract has an ultimate completion date of September 6, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
This is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office Division. The $1,956.25 firm fixed price contract is for the supply of 120 tablets of 10 mg Alfuzosin Hydrochloride Extended-Release tablets, a medication used to treat symptoms of an enlarged prostate. The contract has an ultimate completion date of September 19, 2024. AmerisourceBergen, a large pharmaceutical distributor, has been awarded numerous indefinite delivery...
This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a wholly-owned subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The $1,183.92 contract is for the supply of Alfuzosin Hydrochloride Extended Release (ER) 10 mg tablets. The order has a completion date of February 26, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,626.79, is for the delivery of 120 tablets of Alfuzosin HCl ER 10 mg, a medication used to treat the symptoms of an enlarged prostate. The contract has a completion date of March 6, 2025 and is a firm fixed-price delivery order. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $1,173.75 firm fixed-price contract is for the delivery of 120 tablets of Alfuzosin Hydrochloride Extended-Release 10 mg, a medication used to treat benign prostatic hyperplasia. The contract has a completion date of February 15, 2024 and was awarded on February 14, 2024. It is not designated as a set-aside contract. Amerisourcebergen Drug...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 90-count tablets of Alfuzosin Hydrochloride Extended Release 10 milligram. The contract has a ceiling value of $2,202.21 and a period of performance through March 14, 2024. This delivery order is issued under a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 and...